| 000 | 01749 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517080733.0 | ||
| 264 | 0 | _c20161219 | |
| 008 | 201612s 0 0 eng d | ||
| 022 | _a2326-6074 | ||
| 024 | 7 |
_a10.1158/2326-6066.CIR-15-0267 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNishino, Mizuki | |
| 245 | 0 | 0 |
_aAnti-PD-1 Inhibitor-Related Pneumonitis in Non-Small Cell Lung Cancer. _h[electronic resource] |
| 260 |
_bCancer immunology research _cApr 2016 |
||
| 300 |
_a289-93 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadverse effects |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xcomplications |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Neoplasms _xcomplications |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 | _aNivolumab |
| 650 | 0 | 4 |
_aPneumonia _xdiagnosis |
| 650 | 0 | 4 |
_aPrednisolone _xtherapeutic use |
| 650 | 0 | 4 |
_aProgrammed Cell Death 1 Receptor _xantagonists & inhibitors |
| 650 | 0 | 4 | _aTomography, X-Ray Computed |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aChambers, Emily S | |
| 700 | 1 | _aChong, Curtis R | |
| 700 | 1 | _aRamaiya, Nikhil H | |
| 700 | 1 | _aGray, Stacy W | |
| 700 | 1 | _aMarcoux, J Paul | |
| 700 | 1 | _aHatabu, Hiroto | |
| 700 | 1 | _aJänne, Pasi A | |
| 700 | 1 | _aHodi, F Stephen | |
| 700 | 1 | _aAwad, Mark M | |
| 773 | 0 |
_tCancer immunology research _gvol. 4 _gno. 4 _gp. 289-93 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1158/2326-6066.CIR-15-0267 _zAvailable from publisher's website |
| 999 |
_c25722037 _d25722037 |
||